TU team places first in business plan competition
Thursday, May 29, 2014
Team Owlpal places first in tri-state competition.
University of Tulsa team Owlpal placed first in the Undergraduate Division at the 2014 Donald W. Reynolds tri-state collegiate business plan competition in Las Vegas on May 23.
The top two teams from the undergraduate and graduate divisions at the Governor's Cup competitions held earlier this spring in Oklahoma, Arkansas and Nevada advanced to the tri-state competition, which also included TU teams Valoshade (undergraduate) and AeroHead (graduate).
Owlpal's team leader Jordy Albert and team member MacKenzie Ward designed a proactive mobile health solution for diagnosing and monitoring asthma in children at night. The mobile application uses the internal acoustic capabilities and internal computing power of iOS or Android devices to monitor wheezing and coughing rates for children as they sleep. Albert graduated in 2014 with a bachelor's degree in economics, and Ward is a senior majoring in management. Owlpal's faculty adviser is Claire Cornell, assistant director of entrepreneurship at TU. Owlpal was awarded $30,000 for taking top prize, and Ward received $2,000 for winning the undergraduate division pitch competition.
"Having three TU teams compete at the tri-state level demonstrates that our program equips students with the right combination of academics and real-world experience to develop business ventures with a high potential for success," said Gale Sullenberger, dean of the Collins College of Business. "I congratulate the Owlpal team for its remarkable performance in the competition, under the guidance of Professor Claire Cornell, as well as the AeroHead and Valoshade teams for advancing to the final round."
Albert and Ward will continue to run Owlpal post-competition and are in the process of submitting their application for a digital health accelerator in San Francisco. They hope to spend the summer in San Francisco before returning to Tulsa in the fall to raise their first round of major funding, which will allow them to pursue clearance from the Food and Drug Administration to market Owlpal.